| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |